Transcriptomic Analysis Reveals the Beneficial Effects of Spermidine in an ALS Mouse Model

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by motor neuron and skeletal muscle degeneration.
• Gene expression analysis in an ALS mouse model revealed increased inflammatory pathways and altered mitochondrial and ribosomal gene expression in muscle tissue.

Purpose of the Study:

• To investigate the therapeutic potential of spermidine (SPD) in an ALS mouse model.
• To determine SPD's effects on gene expression, mitochondrial function, and muscle weakness in ALS.

Main Methods:

• Gene expression analysis of spinal cord and gastrocnemius tissue in SOD1-G93A ALS mice.
• Treatment of ALS mice with spermidine (SPD).
• Seahorse experiments to assess mitochondrial bioenergetics and grip strength tests for muscle function.

Main Results:

• SPD treatment partially restored the expression of over four thousand genes in gastrocnemius tissue, including Pgc1α and mitochondrial/ribosomal genes.
• SPD enhanced mitochondrial bioenergetics.
• SPD treatment delayed the onset of muscle weakness in vivo.

Conclusions:

• Spermidine (SPD) demonstrates potential as a therapeutic supplement for Amyotrophic Lateral Sclerosis (ALS).
• SPD's ability to modulate gene expression and improve mitochondrial function offers a promising avenue for future ALS research and treatment strategies.